Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Heart (British Cardiac Society)|October 9, 2014
Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarctionRonak Delewi, Anja M van der Laan, Lourens F H J Robbers, et al.
Circulation. Cardiovascular Interventions|May 1, 2014
Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severityTim P van de Hoef, Martijn A van Lavieren, Peter Damman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 1, 2023
Cardiac output, cerebral blood flow and cognition in patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation: design and rationale of the CAPITA studyAstrid C van Nieuwkerk, Kimberley I Hemelrijk, Esther E Bron, et al.
American Heart Journal|June 7, 2022
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trialRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial areaJeroen M Wilschut, Rosanne F Vogel, Jacob J Elscot, et al.
Journal of Clinical Medicine|October 28, 2023
Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-StudyRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
American Heart Journal|December 17, 2011
A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarctionAnja M van der Laan, Alexander Hirsch, Lourens F H J Robbers, et al.
International Journal of Cardiology|September 11, 2023
Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysisMarleen van Wely, Astrid C van Nieuwkerk, Maxim Rooijakkers, et al.
American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.
Pageof 13